查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576642

微陣列試劑盒市場：產品類型、應用、最終用戶- 2031 年世界預測

Microarray Kits Market by Product Type (DNA [cDNA, Oligo, BAC, SNP], RNA, Protein, Tissue), Application (Drug Discovery & Development, Research, Diagnostic), End User (CRO, Pharma & Biotech, Academic, Hospital & Diagnostic Lab) - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 220 Pages | 商品交期: 5-7個工作天內

價格

該報告基於全面的一手和二手研究以及對市場情景的深入分析，提供了該行業的關鍵推動因素、限制、課題和機會。該市場的推動因素包括微陣列研究應用的增加、微陣列在癌症研究中的使用、個人化醫療的日益採用以及製藥和生物技術行業研發支出的增加。

此外，微陣列技術和新興國家的技術進步正在為該市場創造巨大的成長機會。然而，與其他遺傳方法相比，微陣列的高成本可能會限制該市場的成長。此外，缺乏敏感性和準確性給在該市場運營的公司帶來了重大課題。

目錄

第1章簡介

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 概述
  • 促進因素
    • 在研究中越來越多地使用微陣列
    • 微陣列在癌症研究的應用
    • 個人化醫療的普及
    • 製藥和生技產業的研發費用不斷增加
  • 阻礙因素
    • 與其他基因檢測方法相比，微陣列的成本較高
  • 機會
    • 微陣列技術的進展
    • 新興經濟體
  • 任務
    • 缺乏靈敏度和準確性
  • 趨勢
  • 監管場景
  • 價格分析
  • 價值鏈分析

第5章全球微陣列試劑盒市場：依產品類型

  • 概述
  • DNA 微陣列試劑盒
    • cDNA 微陣列試劑盒
    • 寡核甘酸微陣列試劑盒
    • BAC 微陣列晶片試劑盒
    • SNP 微陣列試劑盒
  • RNA 微陣列試劑盒
  • 蛋白質微陣列試劑盒
  • 組織微陣列試劑盒

第6章全球微陣列試劑盒市場：依應用分類

  • 概述
  • 藥物發現/藥物開發
  • 研究用途
  • 診斷
  • 其他用途

第7章全球微陣列試劑盒市場：依最終用戶分類

  • 概述
  • 製藥和生物技術公司
  • CRO（合同研究組織）
  • 研究和學術機構
  • 醫院/診斷實驗室
  • 其他最終使用者（獸醫院、農業、法醫實驗室）

第8章 微陣列試劑盒市場：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲

第9章 競爭分析

  • 概述
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 市場領導者
    • 差異化因素
    • 先鋒公司
    • 啟動
  • 主要企業市佔率分析/市場排名（2022年）

第10章 公司簡介（公司概況、財務概況、產品組合、策略發展現況）

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Merck KgaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Edvotek Inc.
  • Sakura Finetek USA, Inc.
  • Dextra Laboratories Ltd
  • GeneCopoeia, Inc.
  • 其他公司

（註：將提供前5名企業的SWOT分析）

第11章附錄

Product Code: MRHC - 1041094

The microarray kits market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the increasing research applications of microarrays, the use of microarrays in cancer research, the increasing adoption of personalized medicine, and the growing R&D expenditure in the pharmaceutical and biotechnology industries.

Furthermore, technological advancements in microarray technology and emerging economies provide a significant growth opportunity for this market. However, the higher costs of microarrays, as compared to other genetic methods, may restrain the growth of this market. Additionally, lack of sensitivity and accuracy pose a major challenge for the players operating in this market.

Among product type, in 2024, the DNA microarray kits segment is expected to account for the largest share of the market. DNA microarrays, also known as DNA chips or gene chips, are used in genomics and molecular biology for the simultaneous analysis of thousands to millions of DNA sequences, typically genes or oligonucleotide probes, on a small, solid support surface. The large market share of the segment is attributed to factors such as increasing incidence of cancer, wide application areas of microarray technology, rising funding for genomic R&D, and growing research for personalized medicine.

Among applications, in 2024, the drug discovery & development segment is expected to account for the largest share of the market. Drug discovery & development include the experiments that are conducted to test certain drugs or theories that can be applied to a particular disease treatment. The large market share of the segment is attributed to factors such as growing R&D expenditure, a large number of academic and research institutes focusing on cancer research, and growing innovations in the field of microarray technology.

Among end users, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market. Pharmaceutical and biotechnology companies use microarray kits and technology for various applications such as drug discovery, cancer biomarker detection, and personalized medicines. The large share of the market is attributed to factors such as a growing focus on drug discovery & development, and rising pharmaceutical R&D expenditure, and increased adoption of personalized medicines. In the case of personalized medicine, DNA microarray kits can be used to compare diseased tissues/cells with healthy tissues/cells in order to find the characteristics of a disease. In the case of drug discovery & development, protein microarray kits are used to screen patients and then prescribe drugs to exclude potential side effects and determine the most suitable dose, hence driving the growth of the segment.

An in-depth analysis of the geographical scenario of the global microarray kits market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the global microarray kits market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The largest share of the segment is primarily due to the availability of advanced infrastructure for genomic research, the presence of key players, the presence of key pharmaceutical companies and research institutes, availability of funding for life science research. The presence of key players in the market improves the accessibility to advanced microarray technology resources, including kits.

The key players operating in the global microarray kits market are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).

Scope of the Report:

Microarray Kits Market-by Product Type

  • DNA Microarray Kits
    • cDNA Microarray Kits
    • Oligo Microarray Kits
    • BAC Microarray Kits
    • SNP Microarray Kits
  • RNA Microarray Kits
  • Protein Microarray Kits
  • Tissue Microarray Kits

Microarray Kits Market-by Application

  • Drug Discovery & Development
  • Research Applications
  • Diagnostics
  • Other Applications

(Other applications primarily include agriculture, food & beverages, and forensics)

Microarray Kits Market-by End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research & Academic Institutes
  • Hospitals & Diagnostic Laboratories
  • Other End Users

(Other end users primarily include veterinary clinics, agricultural industry, and forensic laboratories)

Microarray Kits Market-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Research Applications of Microarrays
    • 4.2.2. Use of Microarrays in Cancer Research
    • 4.2.3. Increasing Adoption of Personalized Medicine
    • 4.2.4. Growing R&D Expenditure in Pharmaceutical and Biotechnology Industries
  • 4.3. Restraints
    • 4.3.1. Higher Costs of Microarrays as Compared to Other Genetic Testing Methods
  • 4.4. Opportunities
    • 4.4.1. Technological Advancements in Microarray Technology
    • 4.4.2. Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Lack of Sensitivity and Accuracy
  • 4.6. Trends
  • 4.7. Regulatory Scenario
  • 4.8. Pricing Analysis
  • 4.9. Value Chain Analysis

5. Global Microarray Kits Market-by Product Type

  • 5.1. Overview
  • 5.2. DNA Microarray Kits
    • 5.2.1. cDNA Microarray Kits
    • 5.2.2. Oligo Microarray Kits
    • 5.2.3. BAC Microarray Kits
    • 5.2.4. SNP Microarray Kits
  • 5.3. RNA Microarray Kits
  • 5.4. Protein Microarray Kits
  • 5.5. Tissue Microarray Kits

6. Global Microarray Kits Market-by Application

  • 6.1. Overview
  • 6.2. Drug Discovery & Development
  • 6.3. Research Applications
  • 6.4. Diagnostics
  • 6.5. Other Applications

7. Global Microarray Kits Market-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biotechnology Companies
  • 7.3. Contract Research Organizations
  • 7.4. Research & Academic Institutes
  • 7.5. Hospitals & Diagnostic Laboratories
  • 7.6. Other End Users (Veterinary Clinics, Agricultural Industry, Forensic Laboratories)

8. Microarray Kits Market-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Rest of Asia Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Market Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis/Market Ranking, By Key Players (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Thermo Fisher Scientific, Inc.
  • 10.2. Illumina, Inc.
  • 10.3. Agilent Technologies, Inc.
  • 10.4. Merck KgaA
  • 10.5. PerkinElmer, Inc.
  • 10.6. QIAGEN N.V.
  • 10.7. Edvotek Inc.
  • 10.8. Sakura Finetek USA, Inc.
  • 10.9. Dextra Laboratories Ltd
  • 10.10. GeneCopoeia, Inc.
  • 10.11. Other Companies

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1 Global Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 2 Global DNA Microarray Kits Market, by Type, 2022-2031 (USD Million)
  • Table 3 Global DNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global cDNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Oligo Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global BAC Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global SNP Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global RNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Protein Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Tissue Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 12 Global Microarray Kits Market for Drug Discovery & Development, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Microarray Kits Market for Research Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Microarray Kits Market for Diagnostics, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Microarray Kits Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 17 Global Microarray Kits Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Microarray Kits Market for Contract Research Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Microarray Kits Market for Research & Academic Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Microarray Kits Market for Hospital & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Microarray Kits Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 North America: Microarray Kits Market, by Country, 2022-2031 (USD Million)
  • Table 24 North America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 25 North America: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 26 North America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 27 North America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 28 U.S.: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 29 U.S.: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 30 U.S.: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 31 U.S.: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 32 Canada: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 33 Canada: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 34 Canada: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 35 Canada: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 36 Europe: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Europe: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 38 Europe: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 39 Europe: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 40 Europe: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 41 Germany: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 42 Germany: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 43 Germany: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 44 Germany: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 45 France: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 46 France: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 47 France: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 48 France: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 49 U.K.: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 50 U.K.: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 51 U.K.: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 52 U.K.: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 53 Italy: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 54 Italy: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 55 Italy: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 56 Italy: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 57 Spain: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 58 Spain: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 59 Spain: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 60 Spain: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 61 Rest of Europe: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 62 Rest of Europe: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 63 Rest of Europe: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 64 Rest of Europe: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 65 Asia-Pacific: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 66 Asia-Pacific: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 67 Asia-Pacific: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 68 Asia-Pacific: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 69 Asia-Pacific: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 70 Japan: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 71 Japan: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 72 Japan: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 73 Japan: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 74 China: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 75 China: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 76 China: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 77 China: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 78 India: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 79 India: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 80 India: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 81 India: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 82 Rest of Asia-Pacific: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 83 Rest of Asia-Pacific: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 84 Rest of Asia-Pacific: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 85 Rest of Asia-Pacific: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 86 Latin America: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 87 Latin America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 88 Latin America: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 89 Latin America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 90 Latin America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 91 Brazil: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 92 Brazil: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 93 Brazil: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 94 Brazil: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 95 Mexico: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 96 Mexico: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 97 Mexico: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 98 Mexico: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 99 Rest of Latin America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 100 Rest of Latin America: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 101 Rest of Latin America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 102 Rest of Latin America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 103 Middle East & Africa: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 104 Middle East & Africa: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 105 Middle East & Africa: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 106 Middle East & Africa: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 107 Middle East & Africa: Microarray Kits Market, by End User, 2022-2031 (USD Million)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Microarray Kits Market, by Applications, 2024 VS. 2031 (USD Million)
  • Figure 10 Microarray Kits Market, by Geography
  • Figure 11 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 13 Global Microarray Kits Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Microarray Kits Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 15 North America: Microarray Kits Market Snapshot
  • Figure 16 Europe: Microarray Kits Market Snapshot
  • Figure 17 Asia-Pacific: Microarray Kits Market Snapshot
  • Figure 18 Latin America: Microarray Kits Market Snapshot
  • Figure 19 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 20 Global Microarray Kits Market: Competitive Dashboard
  • Figure 21 Global Microarray Kits Market: Competitive Benchmarking, by Product Type
  • Figure 22 Global Microarray Kits Market: Market Share Analysis/Market Ranking (2024)
  • Figure 23 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
  • Figure 24 Illumina, Inc.: Financial Overview (2022)
  • Figure 25 Agilent Technologies, Inc.: Financial Overview (2024)
  • Figure 26 Merck KGaA: Financial Overview (2022)
  • Figure 27 PerkinElmer, Inc.: Financial Overview (2022)
  • Figure 28 QIAGEN N.V.: Financial Overview (2022)